Total Payments
$84,596
2024 Payments
$48,857
Companies
10
Transactions
195
Payment Breakdown by Category
Other$71,885 (85.0%)
Travel$8,318 (9.8%)
Food & Beverage$4,368 (5.2%)
Education$25.70 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $52,470 | 25 | 62.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,415 | 18 | 23.0% |
| Travel and Lodging | $8,318 | 46 | 9.8% |
| Food and Beverage | $4,368 | 105 | 5.2% |
| Education | $25.70 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Braeburn Inc. | $59,856 | 81 | $0 (2024) |
| Indivior Inc. | $12,823 | 47 | $0 (2021) |
| Alkermes, Inc. | $11,446 | 35 | $0 (2022) |
| Kaleo, Inc. | $178.22 | 13 | $0 (2019) |
| Orexo US, Inc. | $146.29 | 9 | $0 (2020) |
| Bausch Health US, LLC | $58.94 | 3 | $0 (2019) |
| Gilead Sciences, Inc. | $42.55 | 3 | $0 (2020) |
| BioDelivery Sciences International, Inc. | $23.70 | 2 | $0 (2017) |
| Braeburn Pharmaceuticals, Inc. | $11.22 | 1 | $0 (2017) |
| US WorldMeds, LLC | $11.17 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,857 | 62 | Braeburn Inc. ($48,857) |
| 2023 | $10,999 | 19 | Braeburn Inc. ($10,999) |
| 2022 | $17.73 | 1 | Alkermes, Inc. ($17.73) |
| 2021 | $695.98 | 2 | Alkermes, Inc. ($675.00) |
| 2020 | $2,185 | 5 | Alkermes, Inc. ($2,153) |
| 2019 | $12,654 | 46 | Alkermes, Inc. ($8,441) |
| 2018 | $8,420 | 35 | Indivior Inc. ($8,254) |
| 2017 | $767.42 | 25 | Indivior Inc. ($520.08) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $1,980.00 | General |
| Category: Opioid Use Disorder | ||||||
| 12/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $119.70 | General |
| Category: Opioid Use Disorder | ||||||
| 12/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $20.10 | General |
| Category: Opioid Use Disorder | ||||||
| 12/11/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $990.00 | General |
| Category: Opioid Use Disorder | ||||||
| 12/05/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Opioid Use Disorder | ||||||
| 12/05/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Opioid Use Disorder | ||||||
| 11/07/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $1,980.00 | General |
| Category: Opioid Use Disorder | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Opioid Use Disorder | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $40.20 | General |
| Category: Opioid Use Disorder | ||||||
| 09/10/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Opioid Use Disorder | ||||||
| 09/10/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: Opioid Use Disorder | ||||||
| 07/29/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $990.00 | General |
| Category: Opioid Use Disorder | ||||||
| 06/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $2,970.00 | General |
| Category: Opioid Use Disorder | ||||||
| 06/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $196.90 | General |
| Category: Opioid Use Disorder | ||||||
| 06/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $168.37 | General |
| Category: Opioid Use Disorder | ||||||
| 06/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $109.77 | General |
| Category: Opioid Use Disorder | ||||||
| 06/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $3,960.00 | General |
| Category: Opioid Use Disorder | ||||||
| 06/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $453.20 | General |
| Category: Opioid Use Disorder | ||||||
| 06/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $210.60 | General |
| Category: Opioid Use Disorder | ||||||
| 06/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Travel and Lodging | Cash or cash equivalent | $163.33 | General |
| Category: Opioid Use Disorder | ||||||
| 06/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $119.03 | General |
| Category: Opioid Use Disorder | ||||||
| 06/04/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Opioid Use Disorder | ||||||
| 05/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $5,445.00 | General |
| Category: Opioid Use Disorder | ||||||
| 05/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Honoraria | Cash or cash equivalent | $1,980.00 | General |
| Category: Opioid Use Disorder | ||||||
| 05/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $120.20 | General |
| Category: Opioid Use Disorder | ||||||
About Dr. Elizabeth Drew, MD
Dr. Elizabeth Drew, MD is a Family Medicine healthcare provider based in Doylestown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902833718.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Drew, MD has received a total of $84,596 in payments from pharmaceutical and medical device companies, with $48,857 received in 2024. These payments were reported across 195 transactions from 10 companies. The most common payment nature is "Honoraria" ($52,470).
Ad
Practice Information
- Specialty Family Medicine
- Location Doylestown, PA
- Active Since 06/27/2006
- Last Updated 11/19/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902833718
Products in Payments
- BRIXADI (Drug) $59,856
- SUBLOCADE (Drug) $10,673
- VIVITROL (Drug) $9,108
- Vivitrol (Drug) $2,178
- Vivitrol 380 mg (Drug) $159.71
- Evzio (Drug) $157.41
- Zubsolv (Drug) $146.29
- SUBOXONE SUBLINGUAL FILM (Drug) $99.93
- APLENZIN (Drug) $58.94
- BUNAVAIL 2.1 mg 30-count box (Drug) $23.70
- EVZIO (Drug) $20.81
- Probuphine (Drug) $11.22
- Lucemyra/Lofexidine (Drug) $11.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Doylestown
Richard Gaibler, D.o, D.O
Family Medicine — Payments: $5,814
Family Medicine $5,814
Dr. Steven Carver, D.o, D.O
Family Medicine — Payments: $3,842
Family Medicine $3,842
Dr. Robert Grabowski, D.o, D.O
Family Medicine — Payments: $3,033
Family Medicine $3,033
Dr. Michael Barmach, M.d, M.D
Family Medicine — Payments: $3,033
Family Medicine $3,033
Dr. Suzanne Kelly, D.o, D.O
Family Medicine — Payments: $1,893
Family Medicine $1,893
Mary Zoller, M.d, M.D
Family Medicine — Payments: $1,633
Family Medicine $1,633